Pre-silencing of genes involved in the electron transport chain (ETC) pathway is associated with responsiveness to abatacept in rheumatoid arthritis

BACKGROUND: In the current context of personalized medicine, one of the major challenges in the management of rheumatoid arthritis (RA) is to identify biomarkers that predict drug responsiveness. From the European APPRAISE trial, our main objective was to identify a gene expression profile associate...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Arthritis Res Ther
Главные авторы: Derambure, C., Dzangue-Tchoupou, G., Berard, C., Vergne, N., Hiron, M., D’Agostino, M. A., Musette, P., Vittecoq, O., Lequerré, T.
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2017
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5445375/
https://ncbi.nlm.nih.gov/pubmed/28545499
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-017-1319-8
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы